nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—SLC15A1—Lisinopril—systemic scleroderma	0.205	0.265	CbGbCtD
Cephalexin—SLC15A1—Captopril—systemic scleroderma	0.153	0.199	CbGbCtD
Cephalexin—SLC22A6—Captopril—systemic scleroderma	0.0844	0.109	CbGbCtD
Cephalexin—ALB—Captopril—systemic scleroderma	0.0719	0.0933	CbGbCtD
Cephalexin—ALB—Mycophenolate mofetil—systemic scleroderma	0.0566	0.0734	CbGbCtD
Cephalexin—ALB—Prednisone—systemic scleroderma	0.0452	0.0587	CbGbCtD
Cephalexin—SLC22A8—Methotrexate—systemic scleroderma	0.0382	0.0496	CbGbCtD
Cephalexin—CYP2D6—Captopril—systemic scleroderma	0.0354	0.046	CbGbCtD
Cephalexin—SLC22A6—Methotrexate—systemic scleroderma	0.0266	0.0346	CbGbCtD
Cephalexin—ALB—Methotrexate—systemic scleroderma	0.0227	0.0294	CbGbCtD
Cephalexin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0177	0.023	CbGbCtD
Cephalexin—CYP3A4—Prednisone—systemic scleroderma	0.0142	0.0184	CbGbCtD
Cephalexin—Arthralgia—Azathioprine—systemic scleroderma	0.000476	0.00207	CcSEcCtD
Cephalexin—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000474	0.00207	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000473	0.00206	CcSEcCtD
Cephalexin—Leukopenia—Leflunomide—systemic scleroderma	0.000472	0.00206	CcSEcCtD
Cephalexin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000472	0.00206	CcSEcCtD
Cephalexin—Abdominal pain—Mometasone—systemic scleroderma	0.00047	0.00205	CcSEcCtD
Cephalexin—Body temperature increased—Mometasone—systemic scleroderma	0.00047	0.00205	CcSEcCtD
Cephalexin—Agitation—Mycophenolic acid—systemic scleroderma	0.000463	0.00202	CcSEcCtD
Cephalexin—Dyspepsia—Captopril—systemic scleroderma	0.00046	0.00201	CcSEcCtD
Cephalexin—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000459	0.002	CcSEcCtD
Cephalexin—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000456	0.00199	CcSEcCtD
Cephalexin—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000456	0.00199	CcSEcCtD
Cephalexin—Mental disorder—Lisinopril—systemic scleroderma	0.000456	0.00199	CcSEcCtD
Cephalexin—Dizziness—Pentoxifylline—systemic scleroderma	0.000456	0.00199	CcSEcCtD
Cephalexin—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000454	0.00198	CcSEcCtD
Cephalexin—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.000451	0.00197	CcSEcCtD
Cephalexin—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000451	0.00196	CcSEcCtD
Cephalexin—Fatigue—Captopril—systemic scleroderma	0.000451	0.00196	CcSEcCtD
Cephalexin—Arthralgia—Leflunomide—systemic scleroderma	0.000449	0.00196	CcSEcCtD
Cephalexin—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000449	0.00196	CcSEcCtD
Cephalexin—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.000447	0.00195	CcSEcCtD
Cephalexin—Osteoarthritis—Prednisone—systemic scleroderma	0.000447	0.00195	CcSEcCtD
Cephalexin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000447	0.00195	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000446	0.00195	CcSEcCtD
Cephalexin—Skin disorder—Azathioprine—systemic scleroderma	0.000443	0.00193	CcSEcCtD
Cephalexin—Vomiting—Pentoxifylline—systemic scleroderma	0.000438	0.00191	CcSEcCtD
Cephalexin—Convulsion—Mycophenolic acid—systemic scleroderma	0.000436	0.0019	CcSEcCtD
Cephalexin—Rash—Pentoxifylline—systemic scleroderma	0.000435	0.0019	CcSEcCtD
Cephalexin—Dermatitis—Pentoxifylline—systemic scleroderma	0.000434	0.00189	CcSEcCtD
Cephalexin—Headache—Pentoxifylline—systemic scleroderma	0.000432	0.00188	CcSEcCtD
Cephalexin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000431	0.00188	CcSEcCtD
Cephalexin—Feeling abnormal—Captopril—systemic scleroderma	0.000431	0.00188	CcSEcCtD
Cephalexin—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000429	0.00187	CcSEcCtD
Cephalexin—Gastrointestinal pain—Captopril—systemic scleroderma	0.000427	0.00186	CcSEcCtD
Cephalexin—Asthenia—Mometasone—systemic scleroderma	0.000427	0.00186	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000426	0.00186	CcSEcCtD
Cephalexin—Nervous system disorder—Leflunomide—systemic scleroderma	0.000422	0.00184	CcSEcCtD
Cephalexin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000422	0.00184	CcSEcCtD
Cephalexin—Pruritus—Mometasone—systemic scleroderma	0.000421	0.00184	CcSEcCtD
Cephalexin—Skin disorder—Leflunomide—systemic scleroderma	0.000418	0.00182	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000416	0.00181	CcSEcCtD
Cephalexin—Angioedema—Lisinopril—systemic scleroderma	0.000414	0.00181	CcSEcCtD
Cephalexin—Confusional state—Mycophenolic acid—systemic scleroderma	0.000414	0.00181	CcSEcCtD
Cephalexin—Abdominal pain—Captopril—systemic scleroderma	0.000413	0.0018	CcSEcCtD
Cephalexin—Body temperature increased—Captopril—systemic scleroderma	0.000413	0.0018	CcSEcCtD
Cephalexin—Nausea—Pentoxifylline—systemic scleroderma	0.00041	0.00179	CcSEcCtD
Cephalexin—Diarrhoea—Mometasone—systemic scleroderma	0.000407	0.00177	CcSEcCtD
Cephalexin—Leukopenia—Lisinopril—systemic scleroderma	0.000406	0.00177	CcSEcCtD
Cephalexin—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000403	0.00176	CcSEcCtD
Cephalexin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000402	0.00175	CcSEcCtD
Cephalexin—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.0004	0.00174	CcSEcCtD
Cephalexin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000399	0.00174	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000394	0.00172	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000394	0.00172	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000392	0.00171	CcSEcCtD
Cephalexin—Arthralgia—Lisinopril—systemic scleroderma	0.000386	0.00168	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000383	0.00167	CcSEcCtD
Cephalexin—Dyspepsia—Leflunomide—systemic scleroderma	0.000379	0.00165	CcSEcCtD
Cephalexin—Vomiting—Mometasone—systemic scleroderma	0.000378	0.00165	CcSEcCtD
Cephalexin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000376	0.00164	CcSEcCtD
Cephalexin—Rash—Mometasone—systemic scleroderma	0.000375	0.00164	CcSEcCtD
Cephalexin—Asthenia—Captopril—systemic scleroderma	0.000375	0.00163	CcSEcCtD
Cephalexin—Dermatitis—Mometasone—systemic scleroderma	0.000375	0.00163	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000374	0.00163	CcSEcCtD
Cephalexin—Osteoarthritis—Methotrexate—systemic scleroderma	0.000374	0.00163	CcSEcCtD
Cephalexin—Confusional state—Lisinopril—systemic scleroderma	0.000373	0.00163	CcSEcCtD
Cephalexin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000373	0.00163	CcSEcCtD
Cephalexin—Headache—Mometasone—systemic scleroderma	0.000373	0.00163	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000372	0.00162	CcSEcCtD
Cephalexin—Fatigue—Leflunomide—systemic scleroderma	0.000371	0.00162	CcSEcCtD
Cephalexin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00037	0.00161	CcSEcCtD
Cephalexin—Pruritus—Captopril—systemic scleroderma	0.00037	0.00161	CcSEcCtD
Cephalexin—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000365	0.00159	CcSEcCtD
Cephalexin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000363	0.00158	CcSEcCtD
Cephalexin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000362	0.00158	CcSEcCtD
Cephalexin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000362	0.00158	CcSEcCtD
Cephalexin—Neutropenia—Prednisone—systemic scleroderma	0.000361	0.00158	CcSEcCtD
Cephalexin—Abdominal pain—Azathioprine—systemic scleroderma	0.000361	0.00157	CcSEcCtD
Cephalexin—Body temperature increased—Azathioprine—systemic scleroderma	0.000361	0.00157	CcSEcCtD
Cephalexin—Skin disorder—Lisinopril—systemic scleroderma	0.000359	0.00157	CcSEcCtD
Cephalexin—Diarrhoea—Captopril—systemic scleroderma	0.000358	0.00156	CcSEcCtD
Cephalexin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000356	0.00155	CcSEcCtD
Cephalexin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000355	0.00155	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000355	0.00155	CcSEcCtD
Cephalexin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000354	0.00154	CcSEcCtD
Cephalexin—Nausea—Mometasone—systemic scleroderma	0.000353	0.00154	CcSEcCtD
Cephalexin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000352	0.00154	CcSEcCtD
Cephalexin—Dizziness—Captopril—systemic scleroderma	0.000346	0.00151	CcSEcCtD
Cephalexin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000344	0.0015	CcSEcCtD
Cephalexin—Urticaria—Leflunomide—systemic scleroderma	0.000342	0.00149	CcSEcCtD
Cephalexin—Abdominal pain—Leflunomide—systemic scleroderma	0.00034	0.00148	CcSEcCtD
Cephalexin—Body temperature increased—Leflunomide—systemic scleroderma	0.00034	0.00148	CcSEcCtD
Cephalexin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000339	0.00148	CcSEcCtD
Cephalexin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000338	0.00147	CcSEcCtD
Cephalexin—Breast disorder—Methotrexate—systemic scleroderma	0.000338	0.00147	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000337	0.00147	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000337	0.00147	CcSEcCtD
Cephalexin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000336	0.00147	CcSEcCtD
Cephalexin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000336	0.00146	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000336	0.00146	CcSEcCtD
Cephalexin—Vomiting—Captopril—systemic scleroderma	0.000332	0.00145	CcSEcCtD
Cephalexin—Rash—Captopril—systemic scleroderma	0.00033	0.00144	CcSEcCtD
Cephalexin—Dermatitis—Captopril—systemic scleroderma	0.000329	0.00144	CcSEcCtD
Cephalexin—Headache—Captopril—systemic scleroderma	0.000327	0.00143	CcSEcCtD
Cephalexin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000327	0.00143	CcSEcCtD
Cephalexin—Dyspepsia—Lisinopril—systemic scleroderma	0.000326	0.00142	CcSEcCtD
Cephalexin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000325	0.00142	CcSEcCtD
Cephalexin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000325	0.00142	CcSEcCtD
Cephalexin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000324	0.00141	CcSEcCtD
Cephalexin—Eosinophilia—Methotrexate—systemic scleroderma	0.00032	0.00139	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00032	0.00139	CcSEcCtD
Cephalexin—Fatigue—Lisinopril—systemic scleroderma	0.000319	0.00139	CcSEcCtD
Cephalexin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00139	CcSEcCtD
Cephalexin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00138	CcSEcCtD
Cephalexin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000317	0.00138	CcSEcCtD
Cephalexin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000315	0.00137	CcSEcCtD
Cephalexin—Diarrhoea—Azathioprine—systemic scleroderma	0.000312	0.00136	CcSEcCtD
Cephalexin—Haemoglobin—Prednisone—systemic scleroderma	0.000311	0.00136	CcSEcCtD
Cephalexin—Nausea—Captopril—systemic scleroderma	0.00031	0.00135	CcSEcCtD
Cephalexin—Haemorrhage—Prednisone—systemic scleroderma	0.000309	0.00135	CcSEcCtD
Cephalexin—Asthenia—Leflunomide—systemic scleroderma	0.000309	0.00135	CcSEcCtD
Cephalexin—Hallucination—Prednisone—systemic scleroderma	0.000308	0.00134	CcSEcCtD
Cephalexin—Pancytopenia—Methotrexate—systemic scleroderma	0.000307	0.00134	CcSEcCtD
Cephalexin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000305	0.00133	CcSEcCtD
Cephalexin—Pruritus—Leflunomide—systemic scleroderma	0.000305	0.00133	CcSEcCtD
Cephalexin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000304	0.00133	CcSEcCtD
Cephalexin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000303	0.00132	CcSEcCtD
Cephalexin—Neutropenia—Methotrexate—systemic scleroderma	0.000302	0.00132	CcSEcCtD
Cephalexin—Dizziness—Azathioprine—systemic scleroderma	0.000302	0.00131	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000295	0.00129	CcSEcCtD
Cephalexin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000295	0.00129	CcSEcCtD
Cephalexin—Diarrhoea—Leflunomide—systemic scleroderma	0.000295	0.00128	CcSEcCtD
Cephalexin—Urticaria—Lisinopril—systemic scleroderma	0.000294	0.00128	CcSEcCtD
Cephalexin—Body temperature increased—Lisinopril—systemic scleroderma	0.000293	0.00128	CcSEcCtD
Cephalexin—Abdominal pain—Lisinopril—systemic scleroderma	0.000293	0.00128	CcSEcCtD
Cephalexin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000291	0.00127	CcSEcCtD
Cephalexin—Vomiting—Azathioprine—systemic scleroderma	0.00029	0.00126	CcSEcCtD
Cephalexin—Infestation NOS—Methotrexate—systemic scleroderma	0.000288	0.00126	CcSEcCtD
Cephalexin—Infestation—Methotrexate—systemic scleroderma	0.000288	0.00126	CcSEcCtD
Cephalexin—Rash—Azathioprine—systemic scleroderma	0.000288	0.00125	CcSEcCtD
Cephalexin—Dermatitis—Azathioprine—systemic scleroderma	0.000287	0.00125	CcSEcCtD
Cephalexin—Headache—Azathioprine—systemic scleroderma	0.000286	0.00125	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000286	0.00124	CcSEcCtD
Cephalexin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00124	CcSEcCtD
Cephalexin—Dizziness—Leflunomide—systemic scleroderma	0.000285	0.00124	CcSEcCtD
Cephalexin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000281	0.00123	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00028	0.00122	CcSEcCtD
Cephalexin—Immune system disorder—Prednisone—systemic scleroderma	0.000279	0.00122	CcSEcCtD
Cephalexin—Vomiting—Leflunomide—systemic scleroderma	0.000274	0.00119	CcSEcCtD
Cephalexin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000273	0.00119	CcSEcCtD
Cephalexin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000272	0.00119	CcSEcCtD
Cephalexin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000272	0.00118	CcSEcCtD
Cephalexin—Rash—Leflunomide—systemic scleroderma	0.000272	0.00118	CcSEcCtD
Cephalexin—Dermatitis—Leflunomide—systemic scleroderma	0.000271	0.00118	CcSEcCtD
Cephalexin—Mental disorder—Prednisone—systemic scleroderma	0.000271	0.00118	CcSEcCtD
Cephalexin—Nausea—Azathioprine—systemic scleroderma	0.000271	0.00118	CcSEcCtD
Cephalexin—Headache—Leflunomide—systemic scleroderma	0.00027	0.00118	CcSEcCtD
Cephalexin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000269	0.00117	CcSEcCtD
Cephalexin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000267	0.00117	CcSEcCtD
Cephalexin—Asthenia—Lisinopril—systemic scleroderma	0.000266	0.00116	CcSEcCtD
Cephalexin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00116	CcSEcCtD
Cephalexin—Pruritus—Lisinopril—systemic scleroderma	0.000262	0.00114	CcSEcCtD
Cephalexin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000261	0.00114	CcSEcCtD
Cephalexin—Haemoglobin—Methotrexate—systemic scleroderma	0.00026	0.00113	CcSEcCtD
Cephalexin—Rash—Mycophenolic acid—systemic scleroderma	0.000259	0.00113	CcSEcCtD
Cephalexin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000259	0.00113	CcSEcCtD
Cephalexin—Haemorrhage—Methotrexate—systemic scleroderma	0.000259	0.00113	CcSEcCtD
Cephalexin—Hepatitis—Methotrexate—systemic scleroderma	0.000259	0.00113	CcSEcCtD
Cephalexin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000258	0.00112	CcSEcCtD
Cephalexin—Headache—Mycophenolic acid—systemic scleroderma	0.000257	0.00112	CcSEcCtD
Cephalexin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00112	CcSEcCtD
Cephalexin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00112	CcSEcCtD
Cephalexin—Nausea—Leflunomide—systemic scleroderma	0.000256	0.00112	CcSEcCtD
Cephalexin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000255	0.00111	CcSEcCtD
Cephalexin—Urethral disorder—Methotrexate—systemic scleroderma	0.000253	0.00111	CcSEcCtD
Cephalexin—Diarrhoea—Lisinopril—systemic scleroderma	0.000253	0.0011	CcSEcCtD
Cephalexin—Agitation—Prednisone—systemic scleroderma	0.000248	0.00108	CcSEcCtD
Cephalexin—Angioedema—Prednisone—systemic scleroderma	0.000246	0.00107	CcSEcCtD
Cephalexin—Dizziness—Lisinopril—systemic scleroderma	0.000245	0.00107	CcSEcCtD
Cephalexin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000244	0.00107	CcSEcCtD
Cephalexin—Nausea—Mycophenolic acid—systemic scleroderma	0.000244	0.00106	CcSEcCtD
Cephalexin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000239	0.00104	CcSEcCtD
Cephalexin—Vomiting—Lisinopril—systemic scleroderma	0.000235	0.00103	CcSEcCtD
Cephalexin—Immune system disorder—Methotrexate—systemic scleroderma	0.000234	0.00102	CcSEcCtD
Cephalexin—Rash—Lisinopril—systemic scleroderma	0.000233	0.00102	CcSEcCtD
Cephalexin—Convulsion—Prednisone—systemic scleroderma	0.000233	0.00102	CcSEcCtD
Cephalexin—Dermatitis—Lisinopril—systemic scleroderma	0.000233	0.00102	CcSEcCtD
Cephalexin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000233	0.00101	CcSEcCtD
Cephalexin—Headache—Lisinopril—systemic scleroderma	0.000232	0.00101	CcSEcCtD
Cephalexin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000229	0.001	CcSEcCtD
Cephalexin—Arthralgia—Prednisone—systemic scleroderma	0.000229	0.001	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000228	0.000993	CcSEcCtD
Cephalexin—Mental disorder—Methotrexate—systemic scleroderma	0.000227	0.000988	CcSEcCtD
Cephalexin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000967	CcSEcCtD
Cephalexin—Nausea—Lisinopril—systemic scleroderma	0.00022	0.000958	CcSEcCtD
Cephalexin—Anaphylactic shock—Prednisone—systemic scleroderma	0.00022	0.000958	CcSEcCtD
Cephalexin—Nervous system disorder—Prednisone—systemic scleroderma	0.000216	0.00094	CcSEcCtD
Cephalexin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000935	CcSEcCtD
Cephalexin—Skin disorder—Prednisone—systemic scleroderma	0.000214	0.000931	CcSEcCtD
Cephalexin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000899	CcSEcCtD
Cephalexin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000891	CcSEcCtD
Cephalexin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000891	CcSEcCtD
Cephalexin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000203	0.000886	CcSEcCtD
Cephalexin—Leukopenia—Methotrexate—systemic scleroderma	0.000201	0.000878	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.0002	0.000873	CcSEcCtD
Cephalexin—Convulsion—Methotrexate—systemic scleroderma	0.000195	0.00085	CcSEcCtD
Cephalexin—Dyspepsia—Prednisone—systemic scleroderma	0.000193	0.000844	CcSEcCtD
Cephalexin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000193	0.00084	CcSEcCtD
Cephalexin—Arthralgia—Methotrexate—systemic scleroderma	0.000192	0.000835	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00019	0.00083	CcSEcCtD
Cephalexin—Fatigue—Prednisone—systemic scleroderma	0.00019	0.000826	CcSEcCtD
Cephalexin—Confusional state—Methotrexate—systemic scleroderma	0.000185	0.000808	CcSEcCtD
Cephalexin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000184	0.000801	CcSEcCtD
Cephalexin—Feeling abnormal—Prednisone—systemic scleroderma	0.000181	0.00079	CcSEcCtD
Cephalexin—Nervous system disorder—Methotrexate—systemic scleroderma	0.00018	0.000785	CcSEcCtD
Cephalexin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00018	0.000784	CcSEcCtD
Cephalexin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00018	0.000784	CcSEcCtD
Cephalexin—Skin disorder—Methotrexate—systemic scleroderma	0.000178	0.000778	CcSEcCtD
Cephalexin—Urticaria—Prednisone—systemic scleroderma	0.000175	0.000761	CcSEcCtD
Cephalexin—Abdominal pain—Prednisone—systemic scleroderma	0.000174	0.000758	CcSEcCtD
Cephalexin—Body temperature increased—Prednisone—systemic scleroderma	0.000174	0.000758	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000167	0.00073	CcSEcCtD
Cephalexin—Hypersensitivity—Prednisone—systemic scleroderma	0.000162	0.000706	CcSEcCtD
Cephalexin—Dyspepsia—Methotrexate—systemic scleroderma	0.000162	0.000705	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000159	0.000691	CcSEcCtD
Cephalexin—Fatigue—Methotrexate—systemic scleroderma	0.000158	0.00069	CcSEcCtD
Cephalexin—Asthenia—Prednisone—systemic scleroderma	0.000158	0.000688	CcSEcCtD
Cephalexin—Pruritus—Prednisone—systemic scleroderma	0.000156	0.000678	CcSEcCtD
Cephalexin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000151	0.00066	CcSEcCtD
Cephalexin—Diarrhoea—Prednisone—systemic scleroderma	0.00015	0.000656	CcSEcCtD
Cephalexin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00015	0.000655	CcSEcCtD
Cephalexin—Urticaria—Methotrexate—systemic scleroderma	0.000146	0.000636	CcSEcCtD
Cephalexin—Dizziness—Prednisone—systemic scleroderma	0.000145	0.000634	CcSEcCtD
Cephalexin—Abdominal pain—Methotrexate—systemic scleroderma	0.000145	0.000633	CcSEcCtD
Cephalexin—Body temperature increased—Methotrexate—systemic scleroderma	0.000145	0.000633	CcSEcCtD
Cephalexin—Vomiting—Prednisone—systemic scleroderma	0.00014	0.000609	CcSEcCtD
Cephalexin—Rash—Prednisone—systemic scleroderma	0.000139	0.000604	CcSEcCtD
Cephalexin—Dermatitis—Prednisone—systemic scleroderma	0.000138	0.000604	CcSEcCtD
Cephalexin—Headache—Prednisone—systemic scleroderma	0.000138	0.0006	CcSEcCtD
Cephalexin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000135	0.00059	CcSEcCtD
Cephalexin—Asthenia—Methotrexate—systemic scleroderma	0.000132	0.000575	CcSEcCtD
Cephalexin—Nausea—Prednisone—systemic scleroderma	0.000131	0.000569	CcSEcCtD
Cephalexin—Pruritus—Methotrexate—systemic scleroderma	0.00013	0.000567	CcSEcCtD
Cephalexin—Diarrhoea—Methotrexate—systemic scleroderma	0.000126	0.000548	CcSEcCtD
Cephalexin—Dizziness—Methotrexate—systemic scleroderma	0.000121	0.00053	CcSEcCtD
Cephalexin—Vomiting—Methotrexate—systemic scleroderma	0.000117	0.000509	CcSEcCtD
Cephalexin—Rash—Methotrexate—systemic scleroderma	0.000116	0.000505	CcSEcCtD
Cephalexin—Dermatitis—Methotrexate—systemic scleroderma	0.000116	0.000505	CcSEcCtD
Cephalexin—Headache—Methotrexate—systemic scleroderma	0.000115	0.000502	CcSEcCtD
Cephalexin—Nausea—Methotrexate—systemic scleroderma	0.000109	0.000476	CcSEcCtD
